Sustainability report
2022
Vistin Pharma. Sustainability report 2022
We believe in balance in life. We want to grow our business, but not at the expense of the environment, people's wellbeing, or sound business principles.
Keeping the fjord clean
Vistin Pharma. Sustainability report 2022
Balance by Vistin Pharma
Balance by Vistin is established to increase focus on sustainability and create more
Regular surveillance and sampling of the fjord
A good neighbor
Vistin Pharma wants to ensure that we are a good neighbour for the local community, and that we follow our ambition to have no negative impact on environment, people and local community.
We take this seriously and have since 2017 been part of a surveillance program for monitoring effluents in the environment and living species. We make the effort to actually take samples from living organic species in the fjord outside Kragerø nearby our plant on regular basis to ensure we have no negative impact over time.
The results
Latest results from 2022 show no traces of our activities, and proves Vistin's clean operations, something we are very proud of and believe is essential in ensuring long term sustainable operations as a supplier and distinguishing Vistin Pharma from peers.
impact with our initiatives. The sustainability program will structure our efforts and make sure that we work holistically in our company and with our suppliers, partners and customers.
Sampling points In the Kilfjord outside Vistin Pharma facilities to ensure no effluents to sea.
Mette collects samples from the seabed
Balance.
.Balance
Vistin Pharma. Sustainability report 2022
The Balance concept consists of 3 main focus areas.
Healthy environment
Vistin is a «green» and environmentally friendly pharmaceutical company with a "no harm" vision. We have ambitions to be a "front runner" within production and production processes that are environmentally friendly compared to the industry standard. We want to increase production to serve more diabetes 2 patients, but without increased environmental impact on water, air and soil.
People in focus
As a global supplier of key pharmaceutical products Vistin is committed to good governance and committed to be a responsible member of the society. With our culture and ethical guidelines, we rely on all employees to make the right choices and act according to the company's Code of Conduct.
Clean operations
At Vistin we belive in a healthy work environment with happy employees. We have a policy to ensure that all employees have equal opportunities. We assure safe work conditions and nurture a sound business culture for our employees and partners to feel well. We support the development of employees as well as local communities. We expect our suppliers and business partners to support the development and well-being of their employees and contribute to society at large.
Vistin Pharma. Sustainability report 2022
Vistin Pharma's 7 goals for
.
achieving increased sustainability.
1 | Aim to reduce the water consumption in the plant by |
90% through recycling | |
2 | Reduce emission of VOC to air by 90% by 2022 |
3 | Reduce pharmaceutical content in waste |
4 | No increase in discharge to sea from doubled production |
capacity. Innovative process design in expansion project | |
5 | Program for monitoring effluents in the environment and |
living species | |
6 | Change of packaging material in DC granulate product that |
will reduce environmental footprint in fabrication of material, | |
transportation and customer waste generation | |
7 | Reduction of plant energy consumption by optimizing of |
steam and condensate system by heat integration |
Balance.
.Balance
Vistin Pharma. Sustainability report 2022
Vistin in the future.
CO2 footprint
During 2022 Vistin started to measure the Scope 1 and Scope 2 greenhouse gass (GHG) emissions from our manufacturing and energy consumption which is included in this report*. Producing Metformin HCl is a very energy consuming process (>1 Million kWh/month).
Vistin is located in Norway and use only 100% pure sustainable hydropower (rainwater falling from the mountains by gravity and driving electric generators) and therefore the CO2 equivalents from our energy consumption are limited to as little as 10 grams CO2e per produced kg of Metformin API.
This is likely the most environmentally friendly and sustainable production of Metformin API in the world. Vistin has also started the detailed work to analyse our complete Scope 3 emissions in our global supply chain of suppliers, and aspire to include this in the future.
*As baseline for calculations Vistin is using the GHG Protocol and the Science based approach framework to calculate our CO2e
Metric | 2019 | 2020 | 2021 | 2022 | ||||
2023 Objective | 2024 Target | 2030 Vision | Permit 2023 | |||
VOC to air [kg/kg API] | 0,016 | 0,014 | 0,009 | 0,009 | 0,009 | 0,005 | 0,003 | - |
Water use [m3/kg API] | 0,13 | 0,13 | 0,13 | 0,096 | ≤0,075 | ≤0,030 | 0,024 | - |
Butanol to water [g/kg API] | 0,03 | 0,03 | 0,03 | 0,03 | ≤0,03 | ≤0,025 | ≤0,015 | 0,09 |
Metformin to water [g/kg API] | 0,002 | 0,002 | 0,001 | 0,0001 | ≤0,001 | ≤0,001 | ≤0,0005 | 0,05 |
KOF to water [g/kg API] | 0,085 | 0,092 | 0,10 | 0,088 | ≤0,09 | ≤0,09 | ≤0,01 | 0,45 |
Lost time injuries (LTI)@70FTE | 0 | 0 | 9h | 0 | 0 | 0 | 0 | - |
Sick leave [%] | 4,7 | 5,3 | 4,8 | 3,8 | <5 | <5 | <4,5 | - |
Production Volume (Metric ton) | 3048 | 3454 | 3630 | 3640 | 5000-7000 | 5000-7000 | 7000 | - |
Scope 1 CO2e [kg/kg API] | - | - | - | 0,03 | ≤0,03 | 0 | 0 | - |
Scope 2 CO2e [kg/kg API] | - | - | - | 0,01 | ≤0,01 | ≤0,01 | 0 | - |
Scope 1 definition: CO2 equivalents caused by consumption of gas, oil, petrol, diesel in relation to energy production. In 2022 Vistin used some diesel to ensure stable energy from an extra generator during installation of our 2'nd manufacturing line corresponding to 30 grams of CO2e per kg produced API.
Scope 2 definition: CO2 equivalents caused by purchased energy consumption. Vistin consumption of energy is >1 Million kWh/month, and Vistin use only 100% sustainable hydropower from Norway in our manufacturing.
Some examples of sustainability activities already in operation
Compliance with the new 2022 Norwegian Transparency act where all companies in Norway are to analyse the risk of Sosial discrepancy and risk of potential violation of human rights or poor working conditions not following local employer rules and regulations.
The report Is published on the Vistin website.
New freshwater recycling plant
Investment of € 1,5 million In a new freshwater recycling plant to reduce water consumption by 90%
Investment in wastewater discharge tank
To avoid any uncontrolled discharge to the local community sewer.
National surveillance program
Industrial impact on fjords and effluents. Started in 2017.
New VOC investment, Technology development project
Invested approx. € 1 mill to establish a new state of the art VOC to reduce the emission of solvents (butanol) to air by > 95%
-
Balance.
.Balance
vistin.com/sustainability
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Vistin Pharma ASA published this content on 31 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2023 11:09:56 UTC.